C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

“Our goal was very clear from the beginning, which was to develop a user-friendly simple chat-like interface that would provide specific high-quality answers to questions that our members would bring, utilizing only our content,” said Clifford A. Hudis, CEO of the American Society of Clinical Oncology and executive vice chair of the Conquer Cancer Foundation.

October 22, 2025

Vol.51 No.38

Drugs & Targets

ARPA-H selects Tempus as contract research organization for ADAPT Program

Tempus AI was selected by the Advanced Research Projects Agency for Health to provide testing and contract research organization services in support of the agency’s Advanced Analysis for Precision Cancer Therapy program.

October 17, 2025

Vol.51 No.38

Drugs & Targets

Algen Biotechnologies, AstraZeneca form AI drug discovery partnership

Algen Biotechnologies and AstraZeneca are entering into a multi-target research collaboration to advance AI-powered drug discovery in immunology.

October 17, 2025

Vol.51 No.38

Clinical Roundup

OSUCCC–James researchers are using AI to better predict, diagnose lobular cancer

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at the Ohio State University Comprehensive Cancer Center is using artificial intelligence to devise new ways of predicting which patients will develop an aggressive and difficult-to-detect form of breast cancer called lobular cancer, which represents one in every 10 breast cancers diagnosed in the United States.

October 10, 2025

Vol.51 No.37

Cancer Policy

Trump signs order to use AI to accelerate pediatric cancer research

President Trump has signed an executive order to use artificial intelligence to accelerate research in pediatric cancers.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

In Brief

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

UC Davis Health and UCLA are co-leading a newly funded national clinical trial to evaluate whether AI can help radiologists interpret screening mammograms more accurately. The goal is to improve breast cancer detection and reduce unnecessary callbacks and anxiety for patients.

September 26, 2025

Vol.51 No.35

C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

YOU MAY BE INTERESTED IN

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

ARPA-H selects Tempus as contract research organization for ADAPT Program

Algen Biotechnologies, AstraZeneca form AI drug discovery partnership

OSUCCC–James researchers are using AI to better predict, diagnose lobular cancer

Trump signs order to use AI to accelerate pediatric cancer research

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

Renew today!

Subscriber content

Never miss an issue!

Login